Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial ...

Lung cancer leads global cancer mortality, and non-small-cell variants make up more than 80% of cases. Immune checkpoint inhibitors have transformed therapy yet help only 27–45% of recipients.

Lung cancer treatment market expected to surge in coming years. As numerous companies work to advance their lung cancer therapies through the clinic, we can expect an array of new treatment options to ...

The first patient was dosed in the SKYBRIDGE clinical study evaluating peluntamig in combination with the anti-PD-L1 monoclonal antibody Tecentriq (atezolizumab) for extensive-stage small cell lung ...

Following AIS, HPK1 promoted the mobilization of CXCR2 high bone marrow neutrophils. HPK1 loss inhibited peripheral ... the roles of T cell- and cancer cell-intrinsic HPK1 in tumor immunosuppression .

Following AIS, HPK1 promoted the mobilization of CXCR2 high bone marrow neutrophils. HPK1 loss inhibited peripheral neutrophil hyperactivation ... Lung tissues showed alveolar septal thickening and ...

They interact with specific receptors embedded in the plasma membranes of various cells, triggering physiological responses. Among these receptors, CXCR2 is particularly significant, as it is linked ...

IIT Kanpur researchers unveil atomic structure of CXCR2, advancing cancer and respiratory disease research Using cryogenic-electron microscopy (cryo-EM), the research team has mapped the structure ...

About 2.5 million new lung cancer cases were diagnosed worldwide in 2022 – an increase of 300,000 since 2020. The study suggests that environmental factors, ...

Cancer Vaccine for NSCLC Could Be Paradigm-Changing. New study results show that some patients with lung cancer and skin cancer maintained immune responses for 30 weeks after treatment with the ...

Dec. 19, 2024 – The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC). Sold under the brand name Ensacove ...

Susan Wojcicki, the late CEO of YouTube, had a message for the world just weeks before she passed away in August: “Lung cancer among people who have never smoked has been rising significantly.” ...